For investors looking for momentum, Vanguard Mid-Cap Growth ETF (VOT - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 42.1% from its 52-week low of $171.02/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
VOT in Focus
The fund seeks to track the performance of the CRSP US Mid Cap Growth Index. It has AUM of $11.49 billion and charges 7 basis points in annual fees.
Why the Move?
Market participants are upbeat about the impressive second-quarter 2021 earnings results and the rebounding U.S. economy from the coronavirus led-slump. However, rising new delta variant cases are increasing concerns about the sustainability of the economy and earnings growth. Considering the mixed sentiments, mid-cap funds are gaining increased attention as they provide both growth and stability in comparison to the small-cap and large-cap counterparts.
More Gains Ahead?
The fund has a Zacks ETF Rank #2 (Buy). It seems like VOT will remain strong, with a positive weighted alpha of 35.11, which gives cues of further rally.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors looking for momentum, Vanguard Mid-Cap Growth ETF (VOT - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 42.1% from its 52-week low of $171.02/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
VOT in Focus
The fund seeks to track the performance of the CRSP US Mid Cap Growth Index. It has AUM of $11.49 billion and charges 7 basis points in annual fees.
Why the Move?
Market participants are upbeat about the impressive second-quarter 2021 earnings results and the rebounding U.S. economy from the coronavirus led-slump. However, rising new delta variant cases are increasing concerns about the sustainability of the economy and earnings growth. Considering the mixed sentiments, mid-cap funds are gaining increased attention as they provide both growth and stability in comparison to the small-cap and large-cap counterparts.
More Gains Ahead?
The fund has a Zacks ETF Rank #2 (Buy). It seems like VOT will remain strong, with a positive weighted alpha of 35.11, which gives cues of further rally.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on VOT - FREE